➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Baxter
Colorcon
Moodys
AstraZeneca

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020182


Email this page to a colleague

« Back to Dashboard

NDA 020182 describes CARNITOR, which is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the CARNITOR profile page.

The generic ingredient in CARNITOR is levocarnitine. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the levocarnitine profile page.
Summary for 020182
Tradename:CARNITOR
Applicant:Leadiant Biosci Inc
Ingredient:levocarnitine
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 020182
Suppliers and Packaging for NDA: 020182
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARNITOR levocarnitine INJECTABLE;INJECTION 020182 NDA Leadiant Biosciences, Inc. 54482-147 54482-147-01 5 VIAL in 1 CARTON (54482-147-01) > 5 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength200MG/ML
Approval Date:Dec 16, 1992TE:APRLD:Yes
Patent:  Try Before You BuyPatent Expiration:Jan 18, 2021Product Flag?Substance Flag?Delist Request?
Patented Use:USE OF LEVOCARNITINE IN PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY IN PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS
Patent:  Try Before You BuyPatent Expiration:Jan 18, 2021Product Flag?Substance Flag?Delist Request?
Patented Use:USE OF LEVOCARNITINE IN PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY IN PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS
Patent:  Try Before You BuyPatent Expiration:Jan 18, 2021Product Flag?Substance Flag?Delist Request?
Patented Use:USE OF LEVOCARNITINE IN PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY IN PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS

Expired US Patents for NDA 020182

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992   Try Before You Buy   Try Before You Buy
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992   Try Before You Buy   Try Before You Buy
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Harvard Business School
Merck
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.